ASTHMA: diagnosis; monitoring and chronic asthma management. An update on the NEW Joint Guidance.
Webinar
•
Lupin Healthcare
About the CPD course
New guidance has been jointly developed by BTS/NICE/SIGN to improve the diagnosis; monitoring and management of asthma in adults; young people and children. Dr Richard Russell; appointed Chair of the British Thoracic Society Board of Trustees takes us through the guidelines in this webinar.
Lupin Healthcare is a subsidiary of the global pharmaceutical company Lupin Limited, where its heritage lie in generic medicines. Today’s portfolio consists of Respiratory and Neuromuscular medicines and high quality generics with a focus on anti-retroviral and oral contraceptives.The entrepreneurial spirit, external focus and pipeline strength transitions Lupin in the UK from standard generics through to a more specialist organisation partnering with the NHS to deliver value.
